Your browser doesn't support javascript.
loading
Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy.
Blair, Alex B; Wang, Jianxin; Davelaar, John; Baker, Andrew; Li, Keyu; Niu, Nan; Wang, Junke; Shao, Yingkuan; Funes, Vanessa; Li, Pan; Pachter, Jonathan A; Maneval, Daniel C; Dezem, Felipe; Plummer, Jasmine; Chan, Keith Syson; Gong, Jun; Hendifar, Andrew E; Pandol, Stephen J; Burkhart, Richard; Zhang, Yuqing; Zheng, Lei; Osipov, Arsen.
Afiliación
  • Blair AB; Department of Oncology and the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland; The Multidisciplinary Gastrointestinal Cancer Laboratories Program, the
  • Wang J; Department of Oncology and the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland; The Pancreatic Cancer Precision Medic
  • Davelaar J; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
  • Baker A; Department of Oncology and the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Li K; Department of Oncology and the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland; The Pancreatic Cancer Precision Medic
  • Niu N; Department of Oncology and the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland; The Pancreatic Cancer Precision Medic
  • Wang J; Department of Oncology and the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland; The Pancreatic Cancer Precision Medic
  • Shao Y; Department of Oncology and the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland; The Pancreatic Cancer Precision Medic
  • Funes V; Department of Oncology and the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland; The Multidisciplinary Gastrointestinal Cancer Laboratories Program, the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine,
  • Li P; Department of Oncology and the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, Maryland; The Pancreatic Cancer Precision Medic
  • Pachter JA; Verastem Oncology, Needham, Massachusetts.
  • Maneval DC; Halozyme Therapeutics, Inc, San Diego, California.
  • Dezem F; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
  • Plummer J; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
  • Chan KS; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
  • Gong J; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
  • Hendifar AE; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
  • Pandol SJ; Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.
  • Burkhart R; Department of Oncology and the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland; The Multidisciplinary Gastrointestinal Cancer Laboratories Program, the
  • Zhang Y; Department of Medicine, the University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
  • Zheng L; Department of Oncology and the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland; The Multidisciplinary Gastrointestinal Cancer Laboratories Program, the
  • Osipov A; Department of Oncology and the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland; The Multidisciplinary Gastrointestinal Cancer Laboratories Program, the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine,
Gastroenterology ; 163(5): 1267-1280.e7, 2022 11.
Article en En | MEDLINE | ID: mdl-35718227
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Carcinoma Ductal Pancreático / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Gastroenterology Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Carcinoma Ductal Pancreático / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Gastroenterology Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos